Related Experiment Video
Updated: Aug 4, 2026

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts
Published on: November 7, 2019
Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154
1First Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan.
Abstract:
We investigated the effects of MCI-154, a positive inotropic agent that increases the myofilament response to Ca++, on Ca++ transients, left ventricular (LV) function and phosphodiesterase (PDE) III activity of guinea pig heart, and compared them with the effects of pimobendan and milrinone. In Langendorff guinea pig hearts loaded with a fluorescent Ca++ probe indo-1, LV pressure and Ca++ transient were measured simultaneously. MCI-154 (10(-10)-10(-6) M) increased LV developed pressure, +dP/dt and -dP/dt with a reduction of LV end-diastolic pressure, although it did not affect coronary flow. The positive inotropic activity of MCI-154 was more potent than that of pimobendan and milrinone; EC50 values (concentrations for increasing +dP/dt by 50% from base line) were 4.31, 41.5 and 294 x 10(-9) M, respectively. The positive inotropic effect of MCI-154 was accompanied by the increase in systolic, diastolic and amplitude of indo-1 fluorescence ratio. The relative increase in Ca++ transients against the increase in LV contractility produced by MCI-154, however, was significantly less than that by increasing perfusate [Ca++], pimobendan or milrinone. MCI-154 (3 x 10(-7)-10(-4) M) inhibited the activity of PDE III isolated from guinea pig LV tissues, but the inhibitory effect of MCI-154 was less than pimobendan and milrinone; IC50 values were 10.1, 3.5 and 2.4 x 10(-6) M, respectively. These findings suggest that MCI-154 exerts a positive inotropic effect mainly through Ca(++)-sensitizing action in intact beating whole hearts.
Insights
MCI-154, a novel positive inotropic agent, enhances cardiac contractility by increasing myofilament sensitivity to calcium (Ca++). This study reveals MCI-154
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Background:
- Positive inotropic agents are crucial for managing heart failure.
- Understanding the mechanisms of action for new agents like MCI-154 is vital.
- Comparing MCI-154 with existing drugs (pimobendan, milrinone) provides clinical context.
Purpose of the Study:
- To investigate the effects of MCI-154 on calcium (Ca++) transients, left ventricular (LV) function, and phosphodiesterase (PDE) III activity in guinea pig hearts.
- To compare the efficacy and potency of MCI-154 with pimobendan and milrinone.
Main Methods:
- Utilized Langendorff-perfused guinea pig hearts loaded with the fluorescent Ca++ probe indo-1.
- Simultaneously measured LV pressure and Ca++ transients.
- Assessed PDE III activity in isolated guinea pig LV tissues.
Main Results:
- MCI-154 significantly increased LV developed pressure, +dP/dt, and -dP/dt, indicating potent positive inotropic effects.
- MCI-154 demonstrated greater potency than pimobendan and milrinone in increasing contractility (EC50 values).
- The drug increased Ca++ transients but to a lesser extent relative to contractility compared to other agents, suggesting Ca++ sensitization.
Conclusions:
- MCI-154 exerts its positive inotropic effect primarily through calcium sensitization of cardiac myofilaments.
- MCI-154 shows promise as a potent inotropic agent with a distinct mechanism compared to PDE III inhibitors.
- Further research is warranted to explore the therapeutic potential of MCI-154 in cardiovascular conditions.
More Related Videos
05:04In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
Published on: February 22, 2022
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
Heart Failure Drugs: Inotropic Agents